Check out our latest webinar on-demand with Hui Liu, PhD, NeuCyte’s Head of Drug Discovery! Establishing an In Vitro Assay for Effectively Predicting Neurotoxicity Risks Using Functional iPSC-Derived Neurons #drugdiscovery #invitro #neurotox neucytelabs.com/establishingan…

New Webinar On Demand: Establishing an In Vitro Assay for Effectively Predicting ​ Neurotoxicity Risks Using Functional Human iPSC-Derived Neurons​ - mailchi.mp/5efc181fef03/o…

Congratulations to Sifis, Katia & the team on your work on modeling neuroinflammation through a microengineered brain-chip! cell.com/action/showPdf… NeuCyte is honored to be providing the iPSC-derived neurons for this effort.

If you are headed to #AAIC2022, stop by our poster on Aug 1, "Development of iPSC-derived AD platform for phenotypic screening", and find out how our platform enables unique ways to model diseases. Abstract ID 66457, P2-010. #APOE #Tauopathy #neurodegeneration #Alzheimersdisease

Thanks everyone for stopping by our poster at #AAIC22 . Please don't hesitate to reach out to explore collaboration opportunities on modeling neurodegenerative diseases. #invitrodiseasemodeling #alzheimersdisease #drugdiscovery #iPSC

Come us at the NorCal SOT Fall Symposium next week on Tuesday, Sept 27. Discovery how we can assist you on your developmental neurotoxicity (DNT) assessment with our iPSC-derive technology platform. #alternativetoanimaltest #translatableneuroscience neucytelabs.com/news-events

Check out Dr. Suzuki's team's latest publication! See how NeuCyte SynFire® iPSC-derived neurons enable effective detection and classification of drug development risks. Congratulations to Dr. Suzuki and the team!! #neurotoxicity #drugdiscovery jstage.jst.go.jp/article/jts/47…

We thank all our customers, collaborators and business partners for a productive 2022! Check out what we've added to our resource center this year in case you missed anything! neucytelabs.com/resources

We admire the courage and perseverance of all the rare families, advocates, entrepreneurs and scientists. We are committed to continued contribution to developing cures. Please don't hesitate to reach out and see how we can support you. neucyte.com #RareDiseaseDay2023

Meet NeuCyte at our booth, EHS, or #SCSS award reception. Find out how our iPSC neuron-based assays provide powerful predictability for compounds’ seizure liability. Get an update on our latest collaboration with MaxWell Biosystems. More information at neucyte.com/sot2023 #2023SOT

Many thanks to Hui Liu, Martin Nicholson, and to all that joined for a great discussion at our Exhibitor Hosted Session today at #SOT2023. @DNTOX , MaxWell Biosystems Axion BioSystems, Remco Westerink #seizureliability #neurotox #stemcells #3Dculture #organoids #assembloids #MEA #CaImaging

Learn more at neucyte.com/assaydevelopme…

Congrats to Prof. Fritsche, Dr. Bartmann, & the IUF team for the latest publication, "A human iPSC-based in vitro neural network formation assay to investigate neurodevelopmental toxicity of pesticides", in ALTEX. Great working with you! #neurotox #DNT pubmed.ncbi.nlm.nih.gov/37158368/

If you're heading to #ISSCR2023 , make sure to stop by booth 932 and visit our posters. Our scientists are ready to chat with you on how we can support your CNS drug discovery with our hiPSC-based technology platforms and disease modeling capabilities. neucyte.com/isscr2023

At #ISSCR23, NeuCyte has presented posters on developing isogenic iPSC-derived 3D neuroimmune assembloids, and building models for KIF1A associated neurological disorder (a severe children's neurodegenerative disease), respectively. Come see us at booth 932 on Friday, June 16.

We had a very nice time at ISSCR. It was great speaking with everyone who visited our posters, our booth or simply caught up with us. Don't hesitate to reach out and see how we can support your CNS disease modeling and drug discovery with our ever expanding technology platforms.